Steven Cohen Legend Biotech Corp Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Legend Biotech Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 195,371 shares of LEGN stock, worth $6.57 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
195,371
Previous 304,520
35.84%
Holding current value
$6.57 Million
Previous $13.5 Million
29.41%
% of portfolio
0.03%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$375 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$252 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$223 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$192 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$169 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.63B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...